Quiero saber acerca de...

47522

Federal Register / Vol. 86, No. 162 / Wednesday, August 25, 2021 / Notices
comments on or objections to the issuance of the proposed registration on or before September 24, 2021. Such persons may also file a written request for a hearing on the application on or before September 24, 2021.
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: 1 Drug Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and 2 Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

ADDRESSES:

In accordance with 21 CFR 1301.34a, this is notice that on January 20, 2021, Cedarburg Pharmaceuticals, 870 Badger Circle Drive, Grafton, Wisconsin 53024
9436, applied to be registered as an importer of the following basic classes of controlled substances:

SUPPLEMENTARY INFORMATION:

Controlled substance
khammond on DSKJM1Z7X2PROD with NOTICES

Gamma Hydroxybutyric Acid
Marihuana Extract
Marihuana

Drug code
Schedule
2010
7350
7360

I
I I

I

I

The company plans to import Sodium Oxybate derivative of GammaHydroxybutyric Acid to support Euticals Inc. post procurement quota grand. The cannabidiol from Marihuana and Marihuana Extracts is intended for analytical purposes with tetramethylpyrazine. No other activity for this drug code is authorized for this registration.
Approval of permit applications will occur only when the registrants business activity is consistent with what is authorized under 21 U.S.C. 952a2.
Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale.
Brian S. Besser, Acting Assistant Administrator.
FR Doc. 202118233 Filed 82421; 8:45 am BILLING CODE P

VerDate Sep<11>2014

16:54 Aug 24, 2021

Jkt 253001

activity for this drug code is authorized for this registration.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration Docket No. DEA890

FR Doc. 202118238 Filed 82421; 8:45 am
Importer of Controlled Substances Application: Johnson Matthey Inc.

BILLING CODE P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration, Justice.

AGENCY:
ACTION:

Brian S. Besser, Acting Assistant Administrator.

Drug Enforcement Administration
Notice of application.
Docket No. DEA860

Johnson Matthey Inc., has applied to be registered as an importer of basic classes of controlled substances. Refer to Supplementary Information listed below for further drug information.

SUMMARY:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 24, 2021. Such persons may also file a written request for a hearing on the application on or before September 24, 2021.

DATES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: 1 Drug Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and 2 Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

ADDRESSES:

In accordance with 21 CFR 1301.34a, this is notice that on July 23, 2021, Johnson Matthey Inc., 2003 Nolte Drive, West Deptford, New Jersey 080661742, applied to be registered as an importer of the following basic classes of controlled substances:

SUPPLEMENTARY INFORMATION:

Drug code
Controlled substance Nabilone

I

7379

Schedule
I II

The company plans to import Nabilone 7379 in order to accept the return of this controlled substance from a foreign customer who no longer has a demand for this substance. No other
PO 00000

Frm 00054

Fmt 4703

Sfmt 4703

Bulk Manufacturer of Controlled Substances Application: Absolute Standards, Inc.
Drug Enforcement Administration, Justice.
ACTION: Notice of application.
AGENCY:

Absolute Standards, Inc., has applied to be registered as a bulk manufacturer of basic classes of controlled substances. Refer to Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 25, 2021. Such persons may also file a written request for a hearing on the application on or before October 25, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUMMARY:

In accordance with 21 CFR 1301.33a, this is notice that on May 31, 2021, Absolute Standards, Inc., 44 Rossotto Drive, Hamden, Connecticut 065141335, applied to be registered as a bulk manufacturer of the following basic classes of controlled substance:

SUPPLEMENTARY INFORMATION:

Drug code
Controlled substance Pentobarbital

I

2270

Schedule
III

The company plans to bulk manufacture the listed controlled substances for internal use and for sale to its customers. No other activities for these drug codes are authorized for this registration.
Brian S. Besser, Acting Assistant Administrator.
FR Doc. 202118230 Filed 82421; 8:45 am BILLING CODE P

E:FRFM25AUN1.SGM

25AUN1